Warning:  Undefined variable $zfal in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 525 
 
Deprecated:  str_replace(): Passing null to parameter #3 ($subject) of type array|string is deprecated in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 525 
  
 
Warning:  Undefined variable $sterm in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 530 
     free
  
Warning:  Undefined variable $sterm in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 531 
     free
      free 
   English Wikipedia
  Nephropedia Template TP (
  Twit Text
 
  DeepDyve Pubget Overpricing |    
 
  lüll Renal lipid metabolism and lipotoxicity Bobulescu IACurr Opin Nephrol Hypertens  2010[Jul]; 19 (4): 393-402PURPOSE OF REVIEW: Lipid accumulation in nonadipose tissues is increasingly  recognized to contribute to organ injury through a process termed lipotoxicity,  but whether this process occurs in the kidney is still uncertain. This article  briefly summarizes the normal role of lipids in renal physiology and the current  evidence linking excess lipids and lipotoxicity to renal dysfunction. RECENT  FINDINGS: Evidence suggesting that renal lipid accumulation and lipotoxicity may  lead to kidney dysfunction has mounted significantly over recent years. Abnormal  renal lipid content has been described in a number of animal models and has been  successfully manipulated using pharmacologic or genetic strategies. There is some  heterogeneity among studies with regard to the mechanisms, consequences, and  localization of lipid accumulation in the kidney, explainable at least in part by  inherent differences between animal models. The relevance of these findings for  human pathophysiology remains to be established. SUMMARY: Current knowledge on  renal lipid physiology and pathophysiology is insufficient, but provides a strong  foundation and incentive for further exploration. The future holds significant  challenges in this area, especially with regard to applicability of research  findings to the human kidney in vivo, but also the opportunity to transform our  understanding of an array of kidney disorders.|Albumins/metabolism[MESH]|Animals[MESH]|Dyslipidemias[MESH]|Humans[MESH]|Kidney Diseases/physiopathology[MESH]|Kidney/*metabolism/physiology/physiopathology[MESH]|Lipid Metabolism/*physiology[MESH]|Lipids/physiology[MESH]|Triglycerides/metabolism[MESH] |